These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 12144947

  • 21. Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages.
    Hattori Y, Nakanishi N.
    Cell Immunol; 1995 Oct 01; 165(1):7-11. PubMed ID: 7545550
    [Abstract] [Full Text] [Related]

  • 22. Radicicol suppresses expression of inducible nitric-oxide synthase by blocking p38 kinase and nuclear factor-kappaB/Rel in lipopolysaccharide-stimulated macrophages.
    Jeon YJ, Kim YK, Lee M, Park SM, Han SB, Kim HM.
    J Pharmacol Exp Ther; 2000 Aug 01; 294(2):548-54. PubMed ID: 10900231
    [Abstract] [Full Text] [Related]

  • 23. Antipyretic analgesic drugs have different mechanisms for regulation of the expression of inducible nitric oxide synthase in hepatocytes and macrophages.
    Inaba H, Yoshigai E, Okuyama T, Murakoshi M, Sugiyama K, Nishino H, Nishizawa M.
    Nitric Oxide; 2015 Jan 30; 44():61-70. PubMed ID: 25499030
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.
    Paukkeri EL, Leppänen T, Sareila O, Vuolteenaho K, Kankaanranta H, Moilanen E.
    Br J Pharmacol; 2007 Dec 30; 152(7):1081-91. PubMed ID: 17891158
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Induction of inducible nitric oxide synthase expression by 18beta-glycyrrhetinic acid in macrophages.
    Jeong HG, Kim JY.
    FEBS Lett; 2002 Feb 27; 513(2-3):208-12. PubMed ID: 11904152
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Interleukin-13 is a more potent inhibitor of the expression of inducible nitric oxide synthase in smooth muscle cells than in macrophages: a comparison with interleukin-4 and interleukin-10.
    Ruetten H, Thiemermann C.
    Shock; 1997 Dec 27; 8(6):409-14. PubMed ID: 9421853
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by 2'-hydroxychalcone derivatives in RAW 264.7 cells.
    Ban HS, Suzuki K, Lim SS, Jung SH, Lee S, Ji J, Lee HS, Lee YS, Shin KH, Ohuchi K.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1549-57. PubMed ID: 15041472
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.